HPV vaccination willingness and behavior among patients with cervical intraepithelial neoplasia in low-resource areas of Western China: a cross-sectional study

中国西部低收入地区宫颈上皮内瘤变患者HPV疫苗接种意愿和行为:一项横断面研究

阅读:2

Abstract

BACKGROUND: Research on human papillomavirus (HPV) vaccination willingness and behavior among patients with cervical intraepithelial neoplasia (CIN) remains limited, although such evidence is essential for improving disease prevention. METHODS: A knowledge, attitude, practice (KAP) questionnaire was administered to CIN patients aged 20-60 years in Gansu Province, China to explore HPV vaccine willingness and its influencing factors. Logistic regression identified demographic factors associated with vaccination willingness, including patients >45 years. Mediation analysis tested whether knowledge indirectly influenced willingness through attitude and practice. This study also compared the differences between willingness and actual behavior, and restricted cubic splines (RCS) assessed the age-behavior relationship. RESULTS: Among 1,012 patients, 87.45% reported willingness to receive HPV vaccination, while only 27.96% had been vaccinated. Logistic regression showed that patients who were younger, lived in urban areas, had higher education and income, reported frequent sexual activity (>4 times/month), had more sexual partners, and achieved higher KAP scores demonstrated greater willingness (all p < 0.05). Mediation analysis showed that knowledge influenced vaccination willingness mainly through attitude and practice, especially attitude (p < 0.001), while a direct effect was observed only in the chain model. Among participants >45 years old (73.96% willing), those with high-grade squamous intraepithelial lesion (HSIL) were less likely to accept vaccination. RCS revealed a significant non-linear association between age and actual vaccination behavior (p < 0.001). CONCLUSION: Patients showed strong willingness to vaccinate, but the actual vaccination proportion was modest. Misconceptions that infection blocks vaccination may obscure the path to protection. It is recommended to highlight the role of HPV vaccination in preventing recurrence among older HSIL patients and extend the appropriate age of vaccination.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。